The genomic landscape of familial glioma

Glioma is a rare brain tumor with a poor prognosis. Familial glioma is a subset of glioma with a strong genetic predisposition that accounts for approximately 5% of glioma cases. We performed whole-genome sequencing on an exploratory cohort of 203 individuals from 189 families with a history of familial glioma and an additional validation cohort of 122 individuals from 115 families. We found significant enrichment of rare deleterious variants of seven genes in both cohorts, and the most significantly enriched gene was HERC2 (P = 0.0006). Furthermore, we identified rare noncoding variants in both cohorts that were predicted to affect transcription factor binding sites or cause cryptic splicing. Last, we selected a subset of discovered genes for validation by CRISPR knockdown screening and found that DMBT1, HP1BP3, and ZCH7B3 have profound impacts on proliferation. This study performs comprehensive surveillance of the genomic landscape of familial glioma.

[1]  K. Weiss,et al.  A recurrent pathogenic BRCA2 exon 5–11 duplication in the Christian Arab population in Israel , 2021, Familial Cancer.

[2]  M. Groenen,et al.  A natural knockout of the MYO7A gene leads to pre‐weaning mortality in pigs , 2021, Animal genetics.

[3]  J. Crawford,et al.  Mutations in Drosophila crinkled/Myosin VIIA disrupt denticle morphogenesis. , 2020, Developmental biology.

[4]  J. Barnholtz-Sloan,et al.  CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013-2017. , 2020, Neuro-oncology.

[5]  Aaron J. Storey,et al.  Neural cell adhesion molecule 1 is a novel autoantigen in membranous lupus nephritis. , 2020, Kidney international.

[6]  M. Bainbridge.  Determining the incidence of rare diseases , 2020, Human Genetics.

[7]  G. Mills,et al.  PIK3CA variants selectively initiate brain hyperactivity during gliomagenesis , 2020, Nature.

[8]  Ryan L. Collins,et al.  The mutational constraint spectrum quantified from variation in 141,456 humans , 2020, Nature.

[9]  J. L. Rosa,et al.  Regulation of the MDM2‐p53 pathway by the ubiquitin ligase HERC2 , 2019, Molecular oncology.

[10]  C. Delozier,et al.  BRIP-1 germline mutation and its role in colon cancer: presentation of two case reports and review of literature , 2019, BMC Medical Genetics.

[11]  T. Soussi,et al.  High prevalence of cancer‐associated TP53 variants in the gnomAD database: A word of caution concerning the use of variant filtering , 2019, Human mutation.

[12]  David G. Knowles,et al.  Predicting Splicing from Primary Sequence with Deep Learning , 2019, Cell.

[13]  Gregory M. Cooper,et al.  CADD: predicting the deleteriousness of variants throughout the human genome , 2018, Nucleic Acids Res..

[14]  W. Cong,et al.  Phosphoglucomutase 1 inhibits hepatocellular carcinoma progression by regulating glucose trafficking , 2018, PLoS biology.

[15]  Chunlei Liu,et al.  ClinVar: improving access to variant interpretations and supporting evidence , 2017, Nucleic Acids Res..

[16]  Hugues Sicotte,et al.  Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors , 2017, Nature Genetics.

[17]  Ting Wang,et al.  The 3D Genome Browser: a web-based browser for visualizing 3D genome organization and long-range chromatin interactions , 2017, Genome Biology.

[18]  F. Supek,et al.  The rules and impact of nonsense-mediated mRNA decay in human cancers , 2016, Nature Genetics.

[19]  J. Guénet,et al.  The HERC2 ubiquitin ligase is essential for embryonic development and regulates motor coordination , 2016, Oncotarget.

[20]  J. Huse,et al.  IDH-mutant glioma specific association of rs55705857 located at 8q24.21 involves MYC deregulation , 2016, Scientific Reports.

[21]  S. Friend,et al.  The cancer predisposition revolution , 2016, Science.

[22]  David S. Williams,et al.  The unconventional myosin CRINKLED and its mammalian orthologue MYO7A regulate caspases in their signalling roles , 2016, Nature Communications.

[23]  Jennifer B Dennison,et al.  Functional annotation of rare gene aberration drivers of pancreatic cancer , 2016, Nature Communications.

[24]  A. Valencia,et al.  POLE and POLD1 mutations in 529 kindred with familial colorectal cancer and/or polyposis: review of reported cases and recommendations for genetic testing and surveillance , 2015, Genetics in Medicine.

[25]  M. Platzer,et al.  Smg6/Est1 licenses embryonic stem cell differentiation via nonsense-mediated mRNA decay , 2015, The EMBO journal.

[26]  Noam Kaplan,et al.  The Hitchhiker's guide to Hi-C analysis: practical guidelines. , 2015, Methods.

[27]  R. Gibbs,et al.  Germline mutations in shelterin complex genes are associated with familial glioma. , 2015, Journal of the National Cancer Institute.

[28]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[29]  Min Zhu,et al.  HERC2/USP20 coordinates CHK1 activation by modulating CLASPIN stability , 2014, Nucleic acids research.

[30]  G. McVean,et al.  Integrating mapping-, assembly- and haplotype-based approaches for calling variants in clinical sequencing applications , 2014, Nature Genetics.

[31]  G. Karlsson,et al.  A mutation in POLE predisposing to a multi-tumour phenotype , 2014, International journal of oncology.

[32]  Susan M. Chang,et al.  Germline rearrangements in families with strong family history of glioma and malignant melanoma, colon, and breast cancer , 2014, Neuro-oncology.

[33]  Raul Rabadan,et al.  The integrated landscape of driver genomic alterations in glioblastoma , 2013, Nature Genetics.

[34]  Robert Gentleman,et al.  Software for Computing and Annotating Genomic Ranges , 2013, PLoS Comput. Biol..

[35]  S. Shete,et al.  Description of selected characteristics of familial glioma patients - results from the Gliogene Consortium. , 2013, European journal of cancer.

[36]  Peter Donnelly,et al.  Germline mutations in the proof-reading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas , 2012, Nature Genetics.

[37]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..

[38]  J. Lupski,et al.  De novo truncating mutations in ASXL3 are associated with a novel clinical phenotype with similarities to Bohring-Opitz syndrome , 2013, Genome Medicine.

[39]  V. Beneš,et al.  DELLY: structural variant discovery by integrated paired-end and split-read analysis , 2012, Bioinform..

[40]  Darren Hargrave,et al.  Paediatric and adult malignant glioma: close relatives or distant cousins? , 2012, Nature Reviews Clinical Oncology.

[41]  J. Loturco,et al.  A method for stable transgenesis of radial glia lineage in rat neocortex by piggyBac mediated transposition , 2012, Journal of Neuroscience Methods.

[42]  I. Ionita-Laza,et al.  Study Designs for Identification of Rare Disease Variants in Complex Diseases: The Utility of Family-Based Designs , 2011, Genetics.

[43]  David R. Murdock,et al.  Whole-Genome Sequencing for Optimized Patient Management , 2011, Science Translational Medicine.

[44]  N. Mailand,et al.  Assembly and function of DNA double-strand break repair foci in mammalian cells. , 2010, DNA repair.

[45]  B. Scheithauer,et al.  The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.

[46]  P. Kleihues,et al.  Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. , 2005, Journal of neuropathology and experimental neurology.

[47]  D. Holmberg,et al.  Homozygosity mapping of familial glioma in Northern Sweden , 2005, Acta oncologica.

[48]  S. Bennett.  Solexa Ltd. , 2004, Pharmacogenomics.

[49]  Anthony Asher,et al.  Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. , 2003, Journal of neurosurgery.

[50]  J. Kere,et al.  A novel low-penetrance locus for familial glioma at 15q23-q26.3. , 2002, Cancer research.

[51]  K. Czene,et al.  Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish family‐cancer database , 2002, International journal of cancer.

[52]  A. Folsom,et al.  Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. , 1997, American journal of epidemiology.

[53]  R Miike,et al.  Familial and personal medical history of cancer and nervous system conditions among adults with glioma and controls. , 1997, American journal of epidemiology.

[54]  Y. Kubo,et al.  A germline insertion in the tuberous sclerosis (Tsc2) gene gives rise to the Eker rat model of dominantly inherited cancer , 1995, Nature Genetics.

[55]  Patrick Dowd,et al.  Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families , 1994, Nature Genetics.

[56]  W. Blattner,et al.  Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li–Fraumeni syndrome , 1990, Nature.

[57]  P. O'Connell,et al.  Progress towards identifying the neurofibromatosis (NF1) gene. , 1989, Trends in Genetics.